Whole-genome sequencing analysis reveals high specificity of CRISPR/Cas9 and TALEN-based genome editing in human iPSCs - PubMed (original) (raw)
Whole-genome sequencing analysis reveals high specificity of CRISPR/Cas9 and TALEN-based genome editing in human iPSCs
Cory Smith et al. Cell Stem Cell. 2014.
No abstract available
Similar articles
- Advances in therapeutic CRISPR/Cas9 genome editing.
Savić N, Schwank G. Savić N, et al. Transl Res. 2016 Feb;168:15-21. doi: 10.1016/j.trsl.2015.09.008. Epub 2015 Sep 26. Transl Res. 2016. PMID: 26470680 Review. - Rapid Control of Genome Editing in Human Cells by Chemical-Inducible CRISPR-Cas Systems.
Liu KI, Ramli MNB, Sutrisnoh NB, Tan MH. Liu KI, et al. Methods Mol Biol. 2018;1772:267-288. doi: 10.1007/978-1-4939-7795-6_15. Methods Mol Biol. 2018. PMID: 29754234 - Plant genome engineering in full bloom.
Lozano-Juste J, Cutler SR. Lozano-Juste J, et al. Trends Plant Sci. 2014 May;19(5):284-7. doi: 10.1016/j.tplants.2014.02.014. Epub 2014 Mar 24. Trends Plant Sci. 2014. PMID: 24674878 - [CRISPR/Cas system for genome editing in pluripotent stem cells].
Vasil'eva EA, Melino D, Barlev NA. Vasil'eva EA, et al. Tsitologiia. 2015;57(1):19-30. Tsitologiia. 2015. PMID: 25872372 Review. Russian. - Selection and Validation of Spacer Sequences for CRISPR-Cas9 Genome Editing and Transcription Regulation in Bacteria.
Grenier F, Lucier JF, Rodrigue S. Grenier F, et al. Methods Mol Biol. 2015;1334:233-44. doi: 10.1007/978-1-4939-2877-4_15. Methods Mol Biol. 2015. PMID: 26404154
Cited by
- Target specificity of the CRISPR-Cas9 system.
Wu X, Kriz AJ, Sharp PA. Wu X, et al. Quant Biol. 2014 Jun;2(2):59-70. doi: 10.1007/s40484-014-0030-x. Quant Biol. 2014. PMID: 25722925 Free PMC article. - Human Induced Pluripotent Stem Cells as a Platform for Personalized and Precision Cardiovascular Medicine.
Matsa E, Ahrens JH, Wu JC. Matsa E, et al. Physiol Rev. 2016 Jul;96(3):1093-126. doi: 10.1152/physrev.00036.2015. Physiol Rev. 2016. PMID: 27335446 Free PMC article. Review. - Generation of Naivetropic Induced Pluripotent Stem Cells from Parkinson's Disease Patients for High-Efficiency Genetic Manipulation and Disease Modeling.
Hu Z, Pu J, Jiang H, Zhong P, Qiu J, Li F, Wang X, Zhang B, Yan Z, Feng J. Hu Z, et al. Stem Cells Dev. 2015 Nov 1;24(21):2591-604. doi: 10.1089/scd.2015.0079. Epub 2015 Sep 1. Stem Cells Dev. 2015. PMID: 26218671 Free PMC article. - Engineering Human Stem Cell Lines with Inducible Gene Knockout using CRISPR/Cas9.
Chen Y, Cao J, Xiong M, Petersen AJ, Dong Y, Tao Y, Huang CT, Du Z, Zhang SC. Chen Y, et al. Cell Stem Cell. 2015 Aug 6;17(2):233-44. doi: 10.1016/j.stem.2015.06.001. Epub 2015 Jul 2. Cell Stem Cell. 2015. PMID: 26145478 Free PMC article. - Aspects of Gene Therapy Products Using Current Genome-Editing Technology in Japan.
Yamaguchi T, Uchida E, Okada T, Ozawa K, Onodera M, Kume A, Shimada T, Takahashi S, Tani K, Nasu Y, Mashimo T, Mizuguchi H, Mitani K, Maki K. Yamaguchi T, et al. Hum Gene Ther. 2020 Oct;31(19-20):1043-1053. doi: 10.1089/hum.2020.156. Epub 2020 Sep 17. Hum Gene Ther. 2020. PMID: 32731837 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
- P30 CA006973/CA/NCI NIH HHS/United States
- T32 HL007525/HL/NHLBI NIH HHS/United States
- 2R01-HL073781/HL/NHLBI NIH HHS/United States
- R01 HL073781/HL/NHLBI NIH HHS/United States
- U01-HL107446/HL/NHLBI NIH HHS/United States
- T32 GM007814/GM/NIGMS NIH HHS/United States
- U01 HL107446/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials